A.R.T. Advisors’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-24,600
| Closed | -$902K | – | 1440 |
|
|
2019
Q3 | $902K | Buy |
24,600
+16,400
| +200% | +$601K | 0.05% | 597 |
|
|
2019
Q2 | $381K | Sell |
8,200
-59,443
| -88% | -$2.76M | 0.02% | 856 |
|
|
2019
Q1 | $2.72M | Buy |
67,643
+17,200
| +34% | +$691K | 0.16% | 159 |
|
|
2018
Q4 | $2.32M | Buy |
50,443
+41,400
| +458% | +$1.9M | 0.15% | 196 |
|
|
2018
Q3 | $401K | Buy |
+9,043
| New | +$401K | 0.02% | 938 |
|
|
2018
Q2 | – | Sell |
-50,143
| Closed | -$3.63M | – | 1519 |
|
|
2018
Q1 | $3.63M | Buy |
+50,143
| New | +$3.63M | 0.15% | 179 |
|
|
2017
Q4 | – | Sell |
-30,560
| Closed | -$1.53M | – | 1448 |
|
|
2017
Q3 | $1.53M | Sell |
30,560
-24,900
| -45% | -$1.25M | 0.08% | 364 |
|
|
2017
Q2 | $2.57M | Buy |
+55,460
| New | +$2.57M | 0.14% | 203 |
|
|
2016
Q3 | – | Sell |
-23,650
| Closed | -$233K | – | 792 |
|
|
2016
Q2 | $233K | Sell |
23,650
-177,208
| -88% | -$1.75M | 0.01% | 1051 |
|
|
2016
Q1 | $3.4M | Buy |
200,858
+97,112
| +94% | +$1.64M | 0.15% | 189 |
|
|
2015
Q4 | $2.31M | Buy |
103,746
+69,713
| +205% | +$1.55M | 0.11% | 247 |
|
|
2015
Q3 | $802K | Buy |
+34,033
| New | +$802K | 0.03% | 705 |
|
|
2015
Q2 | – | Sell |
-43,696
| Closed | -$4.05M | – | 1539 |
|
|
2015
Q1 | $4.05M | Buy |
43,696
+9,255
| +27% | +$857K | 0.14% | 194 |
|
|
2014
Q4 | $1.39M | Buy |
+34,441
| New | +$1.39M | 0.05% | 513 |
|